Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2024 Jul 31;14(8):965.
doi: 10.3390/life14080965.

Local Allergic Rhinitis-A Challenge for Allergology and Otorhinolaryngology Cooperation (Scoping Review)

Affiliations
Review

Local Allergic Rhinitis-A Challenge for Allergology and Otorhinolaryngology Cooperation (Scoping Review)

Ovidiu Berghi et al. Life (Basel). .

Abstract

Local allergic rhinitis (LAR) represents a medical provocation for allergists and otorhinolaryngologists. LAR is considered to be a subtype of allergic rhinitis (AR) that affects a great percentage of patients who were, for decades, diagnosed as having chronic non-allergic rhinitis. The clinical picture is represented by rhinorrhea, sneezing, and nasal itching correlated with specific pollen season or dust, mold, or pet interior exposure. Usual assessment of AR (skin prick testing and serum IgE assessment) produces negative results. Specialized centers in allergology and ENT around the globe use a nasal allergen challenge, assessment of local IgE, basophil activation test (BAT), and nasal cytology in the diagnostic approach to the disease, taking into account their current limitations. The impact of LAR on quality-of-life indicators is the same as in AR. Treatment for LAR is similar to that for AR and is the same as for AR: allergen exposure avoidance, drug therapy, and allergen immunotherapy. This scoping review gathers the current up-to-date open access evidence available on PubMed on the subject of LAR.

Keywords: ENT; allergology; local allergic rhinitis.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflicts of interest.

Figures

Figure 1
Figure 1
PRISMA flow chart of the present scoping review on LAR.
Figure 2
Figure 2
LAR prevalences in different countries. Colored countries are those for which data are available according to the studies included in this scoping review. The darkest countries are those for which the prevalence is the highest.

References

    1. Mortada M.M., Kurowski M. Challenges in Local Allergic Rhinitis Diagnosis, Management, and Research: Current Concepts and Future Perspectives. Medicina. 2023;59:929. doi: 10.3390/medicina59050929. - DOI - PMC - PubMed
    1. Melone G., Giorgis V., Di Pino M., Pelaia C., Nappi E., Heffler E., Landi M., Gelardi M., Paoletti G. Local Allergic Rhinitis: Lights and Shadows of a Mysterious Entity. Int. Arch. Allergy Immunol. 2023;184:12–20. doi: 10.1159/000526604. - DOI - PubMed
    1. Platts-Mills T.A. Local production of IgG, IgA, and IgE antibodies in grass pollen hay fever. J. Immunol. 1979;122:2218–2225. doi: 10.4049/jimmunol.122.6.2218. - DOI - PubMed
    1. Powe D.G., Jagger C., Kleinjan A., Carney A.S., Jenkins D., Jones N.S. ‘Entropy’: Localized mucosal allergic disease in the absence of systemic responses for atopy. Clin. Exp. Allergy. 2003;33:1374–1379. doi: 10.1046/j.1365-2222.2003.01737.x. - DOI - PubMed
    1. Rondón C., Canto G., Blanca M. Local allergic rhinitis: A new entity, characterization and further studies. Curr. Opin. Allergy Clin. Immunol. 2010;10:1–7. doi: 10.1097/ACI.0b013e328334f5fb. - DOI - PubMed

LinkOut - more resources